Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with cancer. The company is particularly known for its lead product, Iomab-B, which is currently being evaluated in the Phase 3 SIERRA clinical trial. Actinium utilizes its proprietary AWE Technology, which leverages Actinium-225, a radioisotope, to create targeted therapies aimed at improving treatment outcomes for patients. The company is committed to advancing its product pipeline and exploring new therapeutic options in the oncology space. Looking for business intelligence data on Actinium Pharmaceuticals or other suppliers of Pharmaceuticals? Set up your free account with IndustrySelect.
Location Information
Contact Information
Product & Service Information
Map & Driving Directions
Supplier Notes
|
*This form will not be sent to Actinium Pharmaceuticals, Inc. To contact Actinium Pharmaceuticals, Inc. please call the number listed to the left.
|
|
Is this your business? Claim this listing for FREE to update your info, logo, & more! [Video]
Get found! Upgrade your listing to move up in the search results and receive buyer inquiries. |